Caveolin-1 regulates endothelial adhesion of lung cancer cells via reactive oxygen species-dependent mechanism

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• The role of caveolin-1 (Cav-1) in cancer cell adhesion to the endothelium is not fully understood.
• Existing knowledge gaps hinder the development of targeted therapies for cancer metastasis.

Purpose of the Study:

• To elucidate the function of caveolin-1 (Cav-1) in regulating cancer cell-endothelium interactions.
• To investigate the underlying molecular mechanisms by which Cav-1 influences tumor cell adhesion and metastasis.

Main Methods:

• Investigated Cav-1 expression levels during cancer cell detachment and its correlation with endothelial adhesion.
• Utilized ectopic Cav-1 overexpression and shRNA-mediated knockdown to assess its impact on cancer cell adhesion.
• Measured reactive oxygen species (ROS) generation (hydrogen peroxide and hydroxyl radical) and VCAM-1 expression.
• Assessed the role of activated Akt signaling in mediating Cav-1's effects.

Main Results:

• Cav-1 expression down-regulates during cancer cell detachment, inversely correlating with tumor-endothelial adhesion.
• Overexpression of Cav-1 reduced cancer cell adhesion, while Cav-1 knockdown increased it.
• Increased ROS levels during cell detachment contribute to enhanced cancer cell-endothelium interaction via VCAM-1.
• Cav-1 suppresses ROS production by maintaining activated Akt levels, thereby attenuating cell adhesion.

Conclusions:

• Caveolin-1 plays a novel, negative regulatory role in cancer cell adhesion to the endothelium.
• Cav-1 attenuates tumor cell metastasis by suppressing ROS generation through the Akt signaling pathway.
• These findings highlight Cav-1 as a potential therapeutic target for inhibiting lung cancer cell metastasis.